Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT05059444
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Not applicable · Germany, Spain, France, Italy, United States · 57 sites
Registry update: 14 Sept 2026
NCT04968990
Recruiting
Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation
Phase 2 · United States · 1 site
Registry update: 23 Apr 2026
NCT04989959
Recruiting
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
Phase 1 · United States · 1 site
Registry update: 4 Dec 2025
NCT04787042
Recruiting
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Phase 1/2 · United States · 6 sites
Registry update: 15 Nov 2024
NCT04977453
Recruiting
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Phase 1/2 · South Korea, United States · 12 sites
Registry update: 19 Oct 2026
NCT05231655
Recruiting
Ex VIvo DEtermiNed Cancer Therapy
Not applicable · United Kingdom · 1 site
Registry update: 24 Feb 2025
NCT05060783
Recruiting
Renal Cancer Detection With Liquid Biopsy
Not applicable · Denmark · 1 site
Registry update: 30 Jan 2024
NCT04498767
Recruiting
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Not applicable · Belgium, Switzerland, Germany, France, United Kingdom, Italy, Poland · 13 sites
Registry update: 26 Aug 2024
NCT04901702
Recruiting
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/2 · Canada, United States · 10 sites
Registry update: 19 May 2026
NCT04987086
Recruiting
68Ga-PSMA PET in the Renal Cell Carcinoma
Not applicable · China · 9 sites
Registry update: 11 Mar 2026
NCT04895709
Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Phase 1/2 · Australia, Canada, Germany, Spain, Israel, Italy, Japan, United States · 47 sites
Registry update: 17 Aug 2026
NCT04605146
Recruiting
Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy
Not applicable · France · 10 sites
Registry update: 16 Oct 2024
NCT04892849
Recruiting
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
Not applicable · Germany · 1 site
Registry update: 17 Sept 2025
NCT04693377
Recruiting
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Not applicable · United States · 1 site
Registry update: 15 Apr 2026
NCT04777994
Recruiting
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Phase 1 · Spain, France, Israel, Japan, South Korea, United States · 30 sites
Registry update: 4 Jun 2026
NCT04616560
Recruiting
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Phase 2 · United States · 32 sites
Registry update: 12 Nov 2026
NCT04510597
Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Phase 3 · United States · 387 sites
Registry update: 8 Oct 2026
NCT04712305
Recruiting
Urine Omics Predicting IO Therapy Responses in mRCC Patients
Not applicable · Taiwan · 1 site
Registry update: 20 Jan 2022
NCT07743749
Recruiting
An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors
Not applicable · China · 1 site
Registry update: 4 Aug 2026
NCT04659343
Recruiting
TDM for Optimized Outcome in Patients With mRCC.
Not applicable · Denmark · 1 site
Registry update: 4 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.